Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W T Kranert

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Nuklearmedizin. Nuclear Medicine|December 9, 2014
Combination of ultrasound guided percutaneous microwave ablation and radioiodine therapy for treatment of hyper- and hypofunctioning thyroid nodulesC Happel, H Korkusuz, W T Kranert, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 20, 2010
Comparison of positron emission tomography with [(18)F]FDG and [(68)Ga]DOTATOC in recurrent differentiated thyroid cancer: preliminary dataM Middendorp, I Selkinski, C Happel, et al.
Nuklearmedizin. Nuclear Medicine|January 15, 2015
Combination of ultrasound guided percutaneous microwave ablation and radioiodine therapy in benign thyroid diseases. A suitable method to reduce the 131I activity and hospitalization time?Christian Happel, H Korkusuz, D A Koch, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|June 15, 2004
Atypical thoracic and supraclavicular FDG-uptake in patients with Hodgkin's and non-Hodgkin's lymphomaN Döbert, C Menzel, N Hamscho, et al.
Nuklearmedizin. Nuclear Medicine|October 3, 2013
Pre- and intratherapeutical ibritumomab tiuxetan Zevalin® dosimetry in childhoodC Happel, J Diener, W T Kranert, et al.
Nuklearmedizin. Nuclear Medicine|January 9, 2015
Age and body composition influence TSH concentrations after administration of rhTSHF F Holthausen, F von Müller, C Happel, et al.
Nuklearmedizin. Nuclear Medicine|December 7, 2006
FDG uptake after intraarterial chemotherapy in head and neck cancerN Döbert, A F Kovács, C Menzel, et al.
Nuclear Medicine Communications|August 1, 1995
Validation of a dual-isotope technique using 123I-MIBG and 201Tl in the assessment of sympathetic reinnervation following heart transplantation: phantom and patient studiesB J Krause, C Gürtner, W T Kranert, et al.
Endocrine|January 13, 2021
Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of <sup>131</sup>I during radioiodine therapy of Graves' diseaseC Happel, W T Kranert, D Gröner, et al.
The British Journal of Radiology|May 21, 2004
Case report: drug interference with MIBG uptake in a patient with metastatic paragangliomaK Zaplatnikov, C Menzel, N Döbert, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Nuklearmedizin. Nuclear Medicine|December 9, 2014
Combination of ultrasound guided percutaneous microwave ablation and radioiodine therapy for treatment of hyper- and hypofunctioning thyroid nodulesC Happel, H Korkusuz, W T Kranert, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 20, 2010
Comparison of positron emission tomography with [(18)F]FDG and [(68)Ga]DOTATOC in recurrent differentiated thyroid cancer: preliminary dataM Middendorp, I Selkinski, C Happel, et al.
Nuklearmedizin. Nuclear Medicine|January 15, 2015
Combination of ultrasound guided percutaneous microwave ablation and radioiodine therapy in benign thyroid diseases. A suitable method to reduce the 131I activity and hospitalization time?Christian Happel, H Korkusuz, D A Koch, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|June 15, 2004
Atypical thoracic and supraclavicular FDG-uptake in patients with Hodgkin's and non-Hodgkin's lymphomaN Döbert, C Menzel, N Hamscho, et al.
Nuklearmedizin. Nuclear Medicine|October 3, 2013
Pre- and intratherapeutical ibritumomab tiuxetan Zevalin® dosimetry in childhoodC Happel, J Diener, W T Kranert, et al.
Nuklearmedizin. Nuclear Medicine|January 9, 2015
Age and body composition influence TSH concentrations after administration of rhTSHF F Holthausen, F von Müller, C Happel, et al.
Nuklearmedizin. Nuclear Medicine|December 7, 2006
FDG uptake after intraarterial chemotherapy in head and neck cancerN Döbert, A F Kovács, C Menzel, et al.
Nuclear Medicine Communications|August 1, 1995
Validation of a dual-isotope technique using 123I-MIBG and 201Tl in the assessment of sympathetic reinnervation following heart transplantation: phantom and patient studiesB J Krause, C Gürtner, W T Kranert, et al.
Endocrine|January 13, 2021
Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of <sup>131</sup>I during radioiodine therapy of Graves' diseaseC Happel, W T Kranert, D Gröner, et al.
The British Journal of Radiology|May 21, 2004
Case report: drug interference with MIBG uptake in a patient with metastatic paragangliomaK Zaplatnikov, C Menzel, N Döbert, et al.
Pageof 2